Related Experiment Videos
Human submandibular saliva specifically inhibits HIV type 1
T Nagashunmugam1, H M Friedman, C Davis
1Division of Infectious Diseases, School of Medicine, University of Pennsylvania, Philadelphia 19104, USA.
AIDS Research and Human Retroviruses
|March 20, 1997
Summary
Human saliva contains factors that inhibit HIV-1 infectivity. Submandibular saliva shows higher activity, with individual variations in inhibitory levels observed against HIV-1 strains.
Area of Science:
- Immunology
- Virology
- Biochemistry
Background:
- Human saliva contains factors with in vitro anti-HIV-1 activity.
- Previous studies indicated higher anti-HIV-1 activity in submandibular saliva compared to parotid or whole saliva.
- Individual variations in anti-HIV activity were noted, necessitating further investigation.
Purpose of the Study:
- To investigate the anti-HIV-1 inhibitory activity of individual human submandibular saliva samples.
- To assess the impact of filtration on HIV-1 inhibitory activity in submandibular saliva.
- To evaluate the activity of submandibular saliva against laboratory and clinical isolates of HIV-1, HIV-2, and SIV.
Main Methods:
- Collected individual submandibular saliva samples from 15 donors.
- Assessed HIV-1 inhibitory activity in vitro, with and without a filtration step.
- Tested activity against laboratory strains and clinical isolates of HIV-1, HIV-2, and SIV.
Main Results:
- Significant variations in anti-HIV-1 activity were observed among individual saliva samples (9/15 similar, 4/15 less active, 2/15 inactive).
- Filtration generally did not alter activity, but 2 samples showed activity only after filtration.
- Submandibular saliva demonstrated activity against HIV-1 laboratory strains and clinical isolates, but not against HIV-2 or SIV.
Conclusions:
- Individual differences in submandibular saliva composition influence its anti-HIV-1 activity.
- Filtration can be important for detecting inhibitory factors in some individuals.
- Submandibular saliva's anti-HIV-1 activity is relevant against diverse HIV-1 strains, but not other related viruses.